This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
ASCO 2024
All Conferences
View All
PCF
UroToday Home
Conference Highlights
2020 International Bladder Cancer Network
Viewing 1-20 of 32 articles
IBCN 2020: An Evaluation of Single-Sample Tumor Subtype Classification Methods
IBCN 2020: An Exploratory Proteomic Study Delineating the Local and Systemic Immune-Oncologic Profile of Urinary Bladder Cancer Patients
IBCN 2020: Genomic and Transcriptomic Characterization of Metastatic Urothelial Carcinoma
IBCN 2020: Tumor Immune Microenvironment in Response to Radiotherapy Versus BCG in a Murine Model of Bladder Cancer
IBCN 2020: STAG2 and PPARg as Drivers of Luminal-Type Bladder Cancer
IBCN 2020: Extraction-Free Comprehensive Transcriptome Sequencing of Carcinoma in Situ Is Highly Feasible and Insightful in Non-Muscle Invasive Bladder Cancer
IBCN 2020: Identification of New Driver and Passenger Mutations within APOBEC-Induced Hotspot Mutations in Bladder Cancer
IBCN 2020: Genome-Wide CRISPR Screen Reveals SLFN11 as a Potent Mediator of Cisplatin Sensitivity In Muscle-Invasive Bladder Cancer
IBCN 2020: Development and Characterization of a Novel Autochthonous Semi-Spontaneous Bladder Cancer Model By Pathological Evaluation, Single Cell Sequencing and Proteomic Profiling
IBCN 2020: Improving Methods to Detect and Target Nucleotide Excision Repair Deficiency In Bladder Cancer
IBCN 2020: Recurring Urothelial Carcinomas Are Clonal But Incompatible with a Direct Relationship
IBCN 2020: Molecular Correlates of Cisplatin-Based Chemotherapy Response In Muscle-Invasive Bladder Cancer by Integrated Multi-Omics Analysis
IBCN 2020: Recombinant BCG Overexpressing STING Agonist Elicits Trained Immunity and Improved Antitumor Efficacy in Non-Muscle Invasive Bladder Cancer
IBCN 2020: Molecular Profiling of Post-Pembrolizumab Muscle-Invasive Bladder Cancer Reveals Unique Features that May Inspire New Sequential Therapies In Pathological Nonresponders
IBCN 2020: Improving Immune Checkpoint Inhibitor Therapy In Cancer
IBCN 2020: Annual Meeting Highlights and Take-Home Messages
IBCN 2020: Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed with Localized Muscle-Invasive Bladder Cancer: Understanding the Value of Surgical Care
IBCN 2020: Protective Effect of BCG Bladder Instillations on Pneumonia?
IBCN 2020: Lytic Effects of Water on Bladder Cancer Cell Lines: Implications For Clinical Use of Water Irrigation to Reduce Recurrence
IBCN 2020: The Use of Psychotropic Drugs Among Bladder Cancer Patients in the United States
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free